Company facts
- Industry
- Pharmaceutical Preparations
- Headquarters
- San Francisco, California
- Most recent report
- 8-K, filed Aug 13, 2026
- Incorporated
- Delaware
- Filings on record
- 559 filings
- On EDGAR
- CIK 1750284
- Fiscal year ends
- December
- Filer status
- Non-accelerated filer Smaller reporting company
Financials 8 of 23
News 8 of 65
Prospectuses and Registrations 8 of 22
- S-8 Registration statement for an employee plan Mar 16, 2026
- S-3ASR Automatic shelf registration Dec 11, 2025
- 424B5 Prospectus supplement for an offering Nov 19, 2025
- 424B5 Prospectus supplement for an offering Nov 18, 2025
- S-8 Registration statement for an employee plan Mar 18, 2025
- 424B5 Prospectus supplement for an offering Jan 15, 2025
- 424B3 Prospectus supplement for an offering Jan 15, 2025
- S-3 Shelf registration statement Jan 6, 2025
Proxies 8 of 12
- DEFA14A Extra proxy material Apr 29, 2026
- DEF 14A Proxy statement for a shareholder vote Apr 29, 2026
- DEFA14A Extra proxy material Apr 28, 2025
- DEF 14A Proxy statement for a shareholder vote Apr 28, 2025
- DEFA14A Extra proxy material Apr 26, 2024
- DEF 14A Proxy statement for a shareholder vote Apr 26, 2024
- DEFA14A Extra proxy material Apr 28, 2023
- DEF 14A Proxy statement for a shareholder vote Apr 28, 2023
Ownership 8 of 398
- 3 Insider reported their initial holding Aug 13, 2026
- SCHEDULE 13G/A Large holder reported a passive stake, amended Aug 6, 2026
- SCHEDULE 13G/A Large holder reported a passive stake, amended Jul 29, 2026
- 4 Insider reported a trade Jul 27, 2026
- 144 Notice of a proposed sale of restricted stock Jul 24, 2026
- 144 Notice of a proposed sale of restricted stock Jul 23, 2026
- 4 Insider reported a trade Jun 23, 2026
- 4 Insider reported a trade Jun 23, 2026
Other 8 of 39
- ARS Annual report sent to shareholders Apr 29, 2026
- S-3MEF Nov 18, 2025
- ARS Annual report sent to shareholders Apr 28, 2025
- EFFECT Notice that a registration became effective Jan 15, 2025
- EFFECT Notice that a registration became effective Jan 15, 2025
- CORRESP Reply to SEC staff Jan 13, 2025
- CORRESP Reply to SEC staff Jan 13, 2025
- UPLOAD Comment letter from SEC staff Jan 8, 2025
Everything here comes from Olema Pharmaceuticals, Inc.'s own filings on SEC EDGAR. The filing list is rechecked every hour.